These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Khedmat H; Taheri S Ann Transplant; 2009; 14(3):74-7. PubMed ID: 19644164 [TBL] [Abstract][Full Text] [Related]
24. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey. Izadi M; Taheri S Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773 [TBL] [Abstract][Full Text] [Related]
29. [Post-transplantation lymphoproliferative disorder in childhood]. Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879 [TBL] [Abstract][Full Text] [Related]
30. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow. Wang X; Ng CS; Chen C; Yu G; Yin W Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536 [TBL] [Abstract][Full Text] [Related]
31. CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab. Ifthikharuddin JJ; Mieles LA; Rosenblatt JD; Ryan CK; Sahasrabudhe DM Am J Hematol; 2000 Oct; 65(2):171-3. PubMed ID: 10996837 [TBL] [Abstract][Full Text] [Related]
32. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder. Badley AD; Portela DF; Patel R; Kyle RA; Habermann TM; Strickler JG; Ilstrup DM; Wiesner RH; de Groen P; Walker RC; Paya CV Liver Transpl Surg; 1996 Sep; 2(5):375-82. PubMed ID: 9346679 [TBL] [Abstract][Full Text] [Related]
33. Management and outcome of liver recipients with post-transplant lymphoproliferative disease. Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611 [TBL] [Abstract][Full Text] [Related]
34. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey. Khedmat H; Taheri S Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371 [TBL] [Abstract][Full Text] [Related]
35. Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Molmenti EP; Nagata D; Roden J; Squires R; Molmenti H; Casey D; Fasola C; Lopez MJ; Winick N; McPhail W; D'Amico L; Goldstein R; Levy M; Fasola C; Andersen J; Klintmalm G Transplant Proc; 2001; 33(1-2):1727. PubMed ID: 11267487 [No Abstract] [Full Text] [Related]
36. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Nalesnik MA; Makowka L; Starzl TE Curr Probl Surg; 1988 Jun; 25(6):367-472. PubMed ID: 3063441 [No Abstract] [Full Text] [Related]
37. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study. OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265 [TBL] [Abstract][Full Text] [Related]
38. Spectrum of histopathologic diagnosis of lymph node biopsies after liver and kidney transplant. Akar Özkan E; Özdemir BH; Ayva EŞ; Gerçeker F; Boyvat F; Haberal M Exp Clin Transplant; 2015 Apr; 13 Suppl 1():177-82. PubMed ID: 25894150 [TBL] [Abstract][Full Text] [Related]